Dusseldorf - Delayed Quote EUR

Vicore Pharma Holding AB (6Y4.DU)

Compare
0.7530
-0.0040
(-0.53%)
At close: 7:32:26 PM GMT+1
Currency in SEK All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
104,243.0000
--
--
--
--
Gross Profit
104,243.0000
--
--
--
--
Operating Expense
324,292.0000
320,889.0000
287,494.0000
293,420.0000
149,471.0000
Operating Income
-220,049.0000
-320,889.0000
-287,494.0000
-293,420.0000
-149,471.0000
Net Non Operating Interest Income Expense
24,220.0000
10,536.0000
905.0000
635.0000
809.0000
Pretax Income
-196,802.0000
-311,326.0000
-288,806.0000
-296,735.0000
-147,315.0000
Tax Provision
-352.0000
-384.0000
-384.0000
-254.0000
-453.0000
Net Income Common Stockholders
-196,450.0000
-310,942.0000
-288,422.0000
-296,481.0000
-146,862.0000
Diluted NI Available to Com Stockholders
-196,450.0000
-310,942.0000
-288,422.0000
-296,481.0000
-146,862.0000
Total Operating Income as Reported
-220,666.0000
-321,506.0000
-290,725.0000
-294,818.0000
-149,538.0000
Total Expenses
324,292.0000
320,889.0000
287,494.0000
293,420.0000
149,471.0000
Net Income from Continuing & Discontinued Operation
-196,450.0000
-310,942.0000
-288,422.0000
-296,481.0000
-146,862.0000
Normalized Income
-196,094.6367
-310,586.0000
-287,954.0000
-294,360.0000
-146,862.0000
Interest Income
23,871.0000
10,538.0000
913.0000
646.0000
815.0000
Interest Expense
-349.0000
2.0000
8.0000
11.0000
6.0000
Net Interest Income
24,220.0000
10,536.0000
905.0000
635.0000
809.0000
EBIT
-197,151.0000
-311,324.0000
-288,798.0000
-296,724.0000
-147,309.0000
EBITDA
-197,151.0000
-308,031.0000
-285,186.0000
-293,128.0000
-143,772.0000
Reconciled Depreciation
--
3,293.0000
3,612.0000
3,596.0000
3,537.0000
Net Income from Continuing Operation Net Minority Interest
-196,450.0000
-310,942.0000
-288,422.0000
-296,481.0000
-146,862.0000
Total Unusual Items Excluding Goodwill
-356.0000
-356.0000
-468.0000
-2,121.0000
--
Total Unusual Items
-356.0000
-356.0000
-468.0000
-2,121.0000
--
Normalized EBITDA
-196,795.0000
-307,675.0000
-284,718.0000
-291,007.0000
-143,772.0000
Tax Rate for Calcs
0.0000
--
--
--
--
Tax Effect of Unusual Items
-0.6367
--
--
--
--
12/31/2020 - 1/20/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade